See All Slides - tctmd.com

Slides

Presentation TCT 2012

Is This the Next Breakthrough Therapy? Technology and Data Overview

Presenter: Joachim Schofer

October 25, 2012

Presentation TCT 2012

Case 4: My Own Complex Retrograde Approach

Presenter: R. Michael Wyman

October 25, 2012

Presentation TCT 2012

Case Presentation Conclusion: Procedural and Patient Outcomes(2)

Presenter: Andreas Baumbach

October 25, 2012

Presentation TCT 2012

The Aortic Root is the Only Way to Go - No Need for a Debate!

Presenter: Vinayak Bapat

October 25, 2012

$Debate: Enoxaparin or Unfractionated Heparin Plus/Minus Glycoprotein IIb/IIIa Inhibitors Is the Preferred Anticoagulant Strategy During STEMI!$

Presentation TCT 2012

Debate: Enoxaparin or Unfractionated Heparin Plus/Minus Glycoprotein IIb/IIIa Inhibitors Is the Preferred Anticoagulant Strategy During STEMI!

Presenter: Gilles Montalescot

October 25, 2012

Presentation TCT 2012

Case Study(7)

Presenter: Christopher Granger

October 25, 2012

Presentation TCT 2012

Large Medical Device Company Perspectives

Presenter: Tony Blank

October 25, 2012

Presentation TCT 2012

FDA Perspectives

Presenter: Ashwani Sastry

October 25, 2012

Presentation TCT 2012

OCT/FFR Correlation: Do the Combined Technologies Have a Role in Assessing Lesion Severity?

Presenter: Javier Escaned

October 25, 2012

Presentation TCT 2012

The Changing Pattern of AAA Repair in the United States: Is There Still a Role for Elective Open Repair?

Presenter: Zvonimir Krajcer

October 25, 2012

Advertisement

Slides

Is This the Next Breakthrough Therapy? Technology and Data Overview

Case 4: My Own Complex Retrograde Approach

Case Presentation Conclusion: Procedural and Patient Outcomes(2)

The Aortic Root is the Only Way to Go - No Need for a Debate!

Debate: Enoxaparin or Unfractionated Heparin Plus/Minus Glycoprotein IIb/IIIa Inhibitors Is the Preferred Anticoagulant Strategy During STEMI!

Case Study(7)

Large Medical Device Company Perspectives

FDA Perspectives

OCT/FFR Correlation: Do the Combined Technologies Have a Role in Assessing Lesion Severity?

The Changing Pattern of AAA Repair in the United States: Is There Still a Role for Elective Open Repair?

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content